Chemocentryx Inc (CCXI)

$51.99 0.00 (0.00%)

16:00 EDT CCXI Stock Quote Delayed 30 Minutes

7 Dow Stocks With Superior Fundamentals

By Tezcan Gecgil, InvestorPlace Contributor Sep 6, 2022

While investors look for safe bets, here are seven Dow stocks to buy in September.

ChemoCentryx (CCXI) Stock Soars 100% on Amgen Acquisition

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

More Articles

Volume:

Previous Close -

Market Cap 3.71B

PE Ratio -59.76

EPS -0.87

Volume (Avg. Vol.)

Day's Range -

52-Week Range $51.60 - $51.99

Dividend & Yield N/A (N/A)

CCXI Stock Predictions, Articles, and Chemocentryx Inc News

From InvestorPlace
From the Web

CCXI Stock: The Big FDA News That Has ChemoCentryx Shares Skyrocketing 60%

By Brenden Rearick, InvestorPlace Financial News Writer Oct 8, 2021

CCXI stock is making its investors very happy this morning with some huge gains. It's receiving FDA approval for a rare disease treatment.

CCXI Stock: 12 Things to Know About ChemoCentryx as Shares Surge Today

By William White, InvestorPlace Writer Jun 11, 2021

ChemoCentryx (CCXI) stock is on the rise Friday as investors anticipate one of its treatments getting approval from the FDA.

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

By William White, InvestorPlace Writer Jun 11, 2021

Good morning, investors! We're kicking off our coverage today with a look at the biggest pre-market stock movers for Friday.

7 ‘A-Rated’ Aggressive Biotech Stocks to Gamble On

By Louis Navellier and the InvestorPlace Research Staff Sep 22, 2020

The pandemic has raised awareness about the value of biotech across the world. In turn, these biotech stocks will benefit down the road.

7 “Perfect 10” Healthcare Stocks to Buy Now

By Maya Sasson, Writer, TipRanks Mar 18, 2020

Wall Street pros recommend making an investment decision based on multiple factors rather than just a single metric like fundamentals.

4 Top-Ranked Nasdaq Stocks That Have Doubled This Year

By Zacks Investment Research Jun 14, 2018

Investors continued to pour money into the fast-growing companies, doubling the share price of many stocks in the Nasdaq Composite Index. Compare Brokers....

5 Small-Cap ETFs and Stocks Crushing the Russell 2000

By Zacks Investment Research May 21, 2018

We have presented five ETFs & stocks that have easily crushed the Russell 2000 index this year and are likely to continue their strong performance. Compare....

Analysts’ Opinions Are Mixed on These Healthcare Stocks: BioCryst (BCRX), ChemoCentryx (CCXI) and Heska (HSKA)

From TipRanks Aug 11, 2022

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BioCryst (

Analysts Offer Insights on Healthcare Companies: ChemoCentryx (CCXI) and ATI Physical Therapy (ATIP)

From TipRanks Aug 9, 2022

Analysts fell to the sidelines weighing in on ChemoCentryx (

Analysts Offer Insights on Healthcare Companies: Arrowhead Pharmaceuticals (ARWR), ChemoCentryx (CCXI) and Jazz Pharmaceuticals (JAZZ)

From TipRanks Jun 30, 2022

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Arrowhead Pharmaceuticals (

H.C. Wainwright Sticks to Its Buy Rating for ChemoCentryx (CCXI)

From TipRanks Jun 6, 2022

In a report released today, Edward Whit...

Analysts’ Top Healthcare Picks: ChemoCentryx (CCXI), MannKind (MNKD)

From TipRanks Jun 1, 2022

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on ChemoCentryx (

55 Stocks Moving In Friday's Mid-Day Session

From Benzinga May 6, 2022

Gainers Swvl Holdings Corp. (NASDAQ: SWVL) surged 24.4% to $7.50. Swvl Holdings 13D Filing from investor Ahmed Sabbah showed a new 6.4% stake in the company.